Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16020690 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study
Condition: Mucormycosis
Interventions: Drug: deferasirox;   Drug: Placebo;   Drug: Liposomal amphotericin B

Indicates status has not been verified in more than two years